Microbot Medical Inc. announced on March 4, 2025, the appointment of Paul Mullen as its new Vice President of Sales. Mr. Mullen is a seasoned medical device sales expert in the endovascular space and will lead the company’s commercial sales efforts in the United States.
This appointment represents Microbot Medical's first commercial hire, signaling an acceleration of its commercial readiness in anticipation of FDA clearance for the LIBERTY Endovascular Robotic System. Mr. Mullen's immediate responsibilities include building out the sales strategy and infrastructure for a successful launch.
Mr. Mullen brings extensive market experience, having successfully launched innovative technologies and driven efficiencies at companies like Inari Medical, where he was Director of Sales. His track record includes launching the first FDA-cleared thrombectomy device for pulmonary embolism, which is highly relevant to Microbot Medical's market entry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.